Cite
HARVARD Citation
Unemo, M. et al. (2021). High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018. Journal of antimicrobial chemotherapy. pp. 1221-1228. [Online].